miR-34a regulates HDAC1 expression to affect the proliferation and apoptosis of hepatocellular carcinoma

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Hepatocellular carcinoma (HCC) is a major global health concern.
• MicroRNA-34a (miR-34a) is implicated in tumor suppression.
• The role of miR-34a and its interaction with histone deacetylase 1 (HDAC1) in HCC requires further elucidation.

Purpose of the Study:

• To investigate the functional role of miR-34a in HCC.
• To explore the interaction between miR-34a and HDAC1 in HCC.
• To determine if miR-34a can serve as a diagnostic and therapeutic target for HCC.

Main Methods:

• Quantitative real-time PCR (RT-qPCR) to measure miR-34a and HDAC1 expression in 60 HCC tissues.
• Cell transfection with miR-34a mimic in HCC cell lines (HepB3 and HepG2).
• Cell proliferation (CCK8, colony formation) and apoptosis assays (flow cytometry).
• Western blotting to analyze protein expression.
• Bioinformatics analysis, Dual Luciferase Reporter Gene Assay, and retrieval assay to confirm gene targets.

Main Results:

• miR-34a expression was significantly lower in HCC tissues compared to normal tissues.
• HDAC1 expression was significantly higher in HCC tissues compared to normal tissues.
• miR-34a expression was negatively correlated with HDAC1 expression.
• Overexpression of miR-34a inhibited HCC cell proliferation and induced apoptosis.
• miR-34a overexpression altered the expression of apoptosis-related proteins (Bcl-2, procaspase-3, procaspase-9, p21) and c-Myc.
• HDAC1 was identified as a direct target gene of miR-34a, regulated at the 3'UTR.

Conclusions:

• miR-34a plays a crucial role in inhibiting HCC proliferation and inducing apoptosis.
• The mechanism involves the direct regulation of HDAC1 expression by miR-34a.
• miR-34a represents a potential diagnostic biomarker and therapeutic target for hepatocellular carcinoma.